Home › Stocks › KPTI › All Fund Holders
KPTI — KARYOPHARM THERAPEUTICS INC · All Fund Holders
Funds holding (latest): 26 · Reported value held: $64.14M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Goldman Sachs Group history | Q2 2026 | 1.42M | $13.92M | 0.00% | Add |
| BlackRock Inc history | Q2 2026 | 1.42M | $13.86M | 0.00% | Add |
| Two Sigma Investments history | Q2 2026 | 695.26K | $6.79M | 0.01% | Add |
| Geode Capital Management history | Q2 2026 | 531.23K | $5.19M | 0.00% | Add |
| Vanguard Group history | Q4 2025 | 559.62K | $4.12M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 353.55K | $3.45M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 341.68K | $3.34M | 0.00% | Reduce |
| Davidson Kempner Capital Management history | Q2 2026 | 300.00K | $2.93M | 0.04% | Hold |
| Morgan Stanley history | Q2 2026 | 202.51K | $1.98M | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 160.01K | $1.56M | 0.00% | Add |
| Marshall Wace history | Q2 2026 | 128.45K | $1.25M | 0.00% | Hold |
| Renaissance Technologies history | Q2 2026 | 108.21K | $1.06M | 0.00% | Add |
| Balyasny Asset Management history | Q1 2026 | 170.75K | $951.07K | 0.00% | New |
| Invesco Ltd history | Q2 2026 | 90.30K | $882.27K | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 61.94K | $605.18K | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 57.26K | $559.45K | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 49.92K | $487.76K | 0.00% | Add |
| Citigroup Inc history | Q2 2026 | 37.92K | $370.45K | 0.00% | Add |
| Deutsche Bank AG history | Q2 2026 | 19.43K | $189.78K | 0.00% | New |
| Point72 Asset Management history | Q1 2026 | 30.00K | $167.10K | 0.00% | New |
| Wells Fargo & Co history | Q2 2026 | 16.90K | $165.14K | 0.00% | New |
| Citadel Advisors history | Q2 2026 | 13.70K | $133.85K | 0.00% | Reduce |
| Fidelity Management & Research (FMR) history | Q2 2026 | 8.94K | $87.31K | 0.00% | Add |
| JPMorgan Chase & Co history | Q2 2026 | 6.30K | $63.54K | 0.00% | New |
| Legal & General Investment Management America history | Q2 2026 | 1.94K | $18.91K | 0.00% | New |
| T. Rowe Price Associates history | Q2 2026 | 27.23K | $266 | 0.00% | Add |